Home > Anika Therapeutics Salary

Anika Therapeutics Salary

  • 33
  • 26
  • 40
Anika Therapeutics average salary is $92,000, median salary is $92,000 with a salary range from $92,000 to $92,000.
Anika Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Anika Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
92,000
Average
92,000
Median
92,000
High
92,000
Total 1 Anika Therapeutics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Quality Assurance Engineer 92,000-92,000 Los Angeles, CA, 90001 2012 Anika Therapeutics Quality Assurance Engineer Salaries (1)
Anika Therapeutics Los Angeles, CA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Anika Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Anika Therapeutics Jobs
See more Anika Therapeutics Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Anika Therapeutics... Information
  • Anika Therapeutics, Inc.
  • Industry: BioTech/Drugs
  • City: Bedford, MA
  • Headquartered in Woburn, Mass., Anika Therapeutics, Inc. (www.anikatherapeutics.com) develops, manufactures and commercializes therapeutic products and devices intended to promote the repair, protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. In addition to ORTHOVISC(R), a treatment for osteoarthritis of the knee (not approved for sale in the U.S.), Anika markets HYVISC(R) in the U.S. for the treatment of equine osteoarthritis through Boehringer Ingelheim Vetmedica, Inc. and manufactures AMVISC(R) and AMVISC(R) Plus, HA viscoelastic products for ophthalmic surgery, for Bausch & Lomb. It also